SecBot SecBot

BCPC

BALCHEM CORP
Nasdaq· Chemicals & Allied Products· Inc. MD· CIK 0000009326 Materials & Mining
$177.00 +3.77 (+2.18%)
Oct 23 4:00 PM ET · prev $173.23
Market cap
$5.5B
Mid cap
Consensus
Buy
78% Buy or better · 9 analysts
Median target
🔒 Subscribers only
1 year
+13.0%
from $156.68 · Oct 24
30 days
+5.5%
from $167.84
52-week range
$147.36–183.26
−3% from high · low Dec 8
Avg volume 20D
303.8K
shares / day
Short interest
493.0K
≈1.6% of shares · −20.5%
Days to cover
2.1
at average volume
Insider net
$0
no open-market trades · since Feb 8
New fund stakes
2
Q2 2026 13F · 0 exits
Filing reports
8
analyzed by SecBot
SecBot read BULLISH 4 reports · 90 days
Balance 0 bearish · 4 bullish oldest → newest, height = score
Avg score ·High conf. 4/4
Strongest BULLISH Balchem reported another strong quarter with record net sales, net earnings, and adjusted EBITDA, driven by…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Feb 8. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q2 2026: 24 added (2 new), 25 trimmed or exited. Largest new: Boston Trust Walden $32.3M, Arrowstreet Capital, Limited Partnership $14.4M.

  • AnalystsBULLISH

    7 of 9 rate it Buy or better.

  • Short sellersCOVERING

    Short interest −20.5% to 493.0K shares. 2.1 days to cover, ≈1.6% of shares.

  • TrendUPTREND

    3% above its 50-day average.

Who's buying

13F· Q2 2026
2
new positions
0
exits
$46.8M
in new stakes
FundMoveSharesValue
WASATCH ADVISORS LPTRIM1,050,780$177.5M
FIRST TRUST ADVISORS LPADD617,233$104.3M
GOLDMAN SACHS GROUP INCADD272,008$46.0M
Boston Trust Walden CorpNEW191,383$32.3M
MILLENNIUM MANAGEMENT LLCADD184,563$31.2M
PRICE T ROWE ASSOCIATES INC /MD/TRIM111,373$18.8M
MARSHALL WACE, LLPDOUBLED97,856$16.5M
HRT FINANCIAL LPADD86,650$14.6M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 78% rate it Buy or better
Strong Buy2Buy5Hold2Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Aug 3, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
May 4, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Congressional trades
BCPC trades disclosed by members of Congress, with disclosure delay.
1 members · 2 buys / 0 sells
DateMemberTypeAmountDisclosed
Sep 17, 2026
Gilbert Cisneros
D· HOUSE· Balchem Corp
BUY$1,001 - $15,000Oct 13, 2026(27d)
Jul 10, 2026
Gilbert Cisneros
D· HOUSE· Balchem Corp
BUY$1,001 - $15,000Sep 7, 2026(60d)

Insider ledger

Form 4
$0
open-market buys or sells · since Feb 8
DateInsiderTypeValue
Feb 12, 2026
Reid Martin Luther
SVP Chief Supply Chain Officer
TAX W/H$20.6K
Feb 12, 2026
Backus William A.
VP & Chief Accounting Officer
TAX W/H$12.4K
Feb 12, 2026
Harris Theodore L
Chairman, President & CEO
TAX W/H$149.8K
Feb 12, 2026
van Gunsteren Job Leonard
SVP and GM, Specialty Products
TAX W/H$10.3K
Feb 12, 2026
Tignor Michael Brent
SVP & Chief HR Officer
TAX W/H$29.3K
Feb 12, 2026
Bengtsson Carl Martin
EVP & Chief Financial Officer
TAX W/H$53.6K
Feb 12, 2026
Miyata Hatsuki
EVP, CLO, & Secretary
TAX W/H$32.1K
Feb 12, 2026
Boned Frederic
SVP/GM, Human Nutri. & Health
TAX W/H$36.0K

Earnings setup

Estimates

Revision history: 🔒 Fresh data — subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data — subscribers only
Next Q🔒 Fresh data — subscribers only
Current FY🔒 Fresh data — subscribers only
Next FY🔒 Fresh data — subscribers only

Short side

FINRA· Sep 30, 2026
493,011
shares short
-20.5%
vs prior settlement
2.1
days to cover
≈1.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 23, 2026 SEC
Balchem reported another strong quarter with record net sales, net earnings, and adjusted EBITDA, driven by growth…
8-K — Impact 6/10
Oct 23, 2026 SEC
Balchem reported Q3 2026 adjusted EPS of $1.57, a 2.3% beat vs consensus of $1.53, on record net sales of $290.7M…
PRESS-RELEASE — Impact 6/10
Oct 23, 2026 Earnings
Balchem Corporation Reports Third Quarter 2026 Financial Results
Balchem Corporation Reports Third Quarter 2026 Financial Results
Sep 17, 2026 Congress
Gilbert Cisneros buy
$1,001 - $15,000 — House
Jul 31, 2026 SEC
Balchem Corporation reported Q2 2026 adjusted EPS of $1.49 on revenue of $284.0M, beating consensus estimates of $1.43…
PRESS-RELEASE — Impact 6/10
Jul 10, 2026 Congress
Gilbert Cisneros buy
$1,001 - $15,000 — House
Jun 30, 2026 Inst.
WASATCH ADVISORS LP — TRIM
1,050,780 shares ($177.5M)
Jun 30, 2026 Inst.
FIRST TRUST ADVISORS LP — ADD
617,233 shares ($104.3M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Oct 23, 2026
Earnings
Balchem Corporation Reports Third Quarter 2026 Financial Results
Balchem Corporation Reports Third Quarter 2026 Financial Results
Oct 23, 2026
Earnings result
BCPC Q3 2026 Earnings: EPS $1.57 (+0.3% vs est)
Oct 19, 2026
Earnings date
BCPC Q3 2026 Earnings Scheduled — 2026-10-19
Sep 9, 2026
Press release
Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026
Balchem Corporation to Participate in the 9th Annual Wells Fargo Consumer Conference
Jul 31, 2026
Earnings
Balchem Corporation Reports Second Quarter 2026 Financial Results
Balchem Corporation Reports Second Quarter 2026 Financial Results

SecBot reports

8 filings · 4 bullish · 0 bearish · 4 neutral
All BCPC filing & press-release reports (8)